Literature DB >> 16963184

Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients.

Donald D Price1, Jason Craggs, G Nicholas Verne, William M Perlstein, Michael E Robinson.   

Abstract

Previous experiments found that placebos produced small decreases in neural activity of pain-related areas of the brain, yet decreases were only statistically significant after termination of stimuli and in proximity to when subjects rated them. These changes could reflect report bias rather than analgesia. This functional magnetic resonance imaging (fMRI) study examined whether placebo analgesia is accompanied by reductions in neural activity in pain-related areas of the brain during the time of stimulation. Brain activity of irritable bowel syndrome patients was measured in response to rectal distension by a balloon barostat. Large reductions in pain and in brain activation within pain-related regions (thalamus, somatosensory cortices, insula, and anterior cingulate cortex) occurred during the placebo condition. Results indicate that decreases in activity were related to placebo suggestion and a second factor (habituation/attention/conditioning). Although many factors influence placebo analgesia, it is accompanied by reduction in pain processing within the brain in clinically relevant conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963184     DOI: 10.1016/j.pain.2006.08.001

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  87 in total

Review 1.  The placebo effect: advances from different methodological approaches.

Authors:  Karin Meissner; Ulrike Bingel; Luana Colloca; Tor D Wager; Alison Watson; Magne Arve Flaten
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain.

Authors:  Martina Amanzio; Fabrizio Benedetti; Carlo A Porro; Sara Palermo; Franco Cauda
Journal:  Hum Brain Mapp       Date:  2011-11-29       Impact factor: 5.038

Review 3.  [Mechanisms of endogenous pain modulation illustrated by placebo analgesia : functional imaging findings].

Authors:  U Bingel
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

4.  Individual expectation: an overlooked, but pertinent, factor in the treatment of individuals experiencing musculoskeletal pain.

Authors:  Joel E Bialosky; Mark D Bishop; Joshua A Cleland
Journal:  Phys Ther       Date:  2010-06-30

5.  Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.

Authors:  Irene Tracey
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

6.  Placebo Analgesia - Understanding the Mechanisms and Implications for Clinical Practice.

Authors:  Damien G Finniss; Michael K Nicholas; Fabrizio Benedetti
Journal:  Rev Pain       Date:  2009-10

Review 7.  The placebo effect: From concepts to genes.

Authors:  B Colagiuri; L A Schenk; M D Kessler; S G Dorsey; L Colloca
Journal:  Neuroscience       Date:  2015-08-10       Impact factor: 3.590

Review 8.  Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review.

Authors:  Ulrike Bingel; Luana Colloca; Lene Vase
Journal:  Gerontology       Date:  2010-10-26       Impact factor: 5.140

9.  Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain.

Authors:  Johanna M Jarcho; Natasha A Feier; Alberto Bert; Jennifer A Labus; Maunoo Lee; Jean Stains; Bahar Ebrat; Stephanie M Groman; Kirsten Tillisch; Arthur L Brody; Edythe D London; Mark A Mandelkern; Emeran A Mayer
Journal:  Pain       Date:  2013-03-05       Impact factor: 6.961

Review 10.  The Role of Patient-Practitioner Relationships in Placebo and Nocebo Phenomena.

Authors:  Maxie Blasini; Nathalie Peiris; Thelma Wright; Luana Colloca
Journal:  Int Rev Neurobiol       Date:  2018-08-09       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.